Article
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients.
Pharmacogenomics - 1 Jan 2015
Hareedy Mohammad Salem, El Desoky Ehab S, Woillard Jean-Baptiste, Thabet Romany Helmy, Ali Amany Mohamad, Marquet Pierre, Picard Nicolas
Abstract excerpt
AIM: We investigated the associations between variants in genes coding for enzymes and transporters related to the 6-mercaptopurine pathway and clinical outcomes in pediatric patients with acute lymphoblastic leukemia. MATERIALS & METHODS: Statistical association between gender, age and genotypes of selected SNPs, and the risks of hematological toxicity and relapse were investigated using a Cox proportional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
